Vial Provider Comparison
Direct Peptides vs Peptide Partners
Same category. Different operational transparency.
Direct Peptides
Grey Market VendorUSE CAUTION
65/ 100
Vial Trust Score
Peptide Partners
Grey Market VendorUSE CAUTION
60/ 100
Vial Trust Score
SignalDirect PeptidesPeptide Partners
Pharmacy Disclosure
Do they name their pharmacy partner?
✕No pharmacy partner named
✕No pharmacy partner named
Physician Oversight
Are prescribing clinicians named?
✕No clinician disclosure
✕No clinician disclosure
Pricing Transparency
Is pricing shown before signup?
✓Public pricing (Premium)
✓Public pricing (Mid)
Federal Enforcement History
Any FDA, DEA, or OIG actions?
✓No federal actions found
✓No federal actions found
State Availability
How widely is care available?
✓Available in all 50 states
✓Available in all 50 states
Membership Model
Is a paid membership required?
✓No membership required
✓No membership required
Data & Privacy
Any reported HIPAA breaches?
✓No breaches on record
✓No breaches on record
More disclosure
Direct Peptides
Holds the broader public record across the signals Vial tracks.
Less disclosure
Peptide Partners
Gaps in pharmacy disclosure and physician oversight.
Updated May 26, 2026
Scores based on operational, compliance, and transparency signals tracked by Vial.
Found this helpful? Share it.
Help others get informed.
Other matchups
Related comparisons
65Direct Peptides
65SwissChems
Same scoreSee the gap →
60Peptide Partners
65SwissChems
5-point gapSee the gap →
65Direct Peptides
64Hallandale Health
1-point gapSee the gap →
64Hallandale Health
60Peptide Partners
4-point gapSee the gap →
64Blue Sky Peptide
65Direct Peptides
1-point gapSee the gap →
64Blue Sky Peptide
60Peptide Partners
4-point gapSee the gap →